Ai. Sacaan et al., EPIBATIDINE - A NICOTINIC ACETYLCHOLINE-RECEPTOR AGONIST RELEASES MONOAMINERGIC NEUROTRANSMITTERS - IN-VITRO AND IN-VIVO EVIDENCE IN RATS, The Journal of pharmacology and experimental therapeutics, 276(2), 1996, pp. 509-515
The effect of the neuronal acetylcholine-gated ion channel receptor ag
onist (+/-)-epibatidine was studied on neurotransmitter release in vit
ro and motor behavior in vivo. (+/-)-Epibatidine (3-300 nM) caused a c
oncentration- and calcium-dependent release of [H-3]-dopamine from str
iatal slices and [H-3]-norepinephrine release from hippocampal and tha
lamic slices. (+/-)-Epibatidine-induced neurotransmitter release was i
nhibited in all three regions by mecamylamine (3 mu M). In contrast, D
-tubocurarine (10-100 mu M) inhibited only (+/-)-epibatidine-induced [
H-3]-norepinephrine release from the hippocampus and the thalamus. Con
versely, dihydro beta-erythroidine (3-100 mu M) inhibited (+/-)-epibat
idine-induced [H-3]-dopamine release in the striatum without significa
ntly altering [H-3]-norepinephrine release from either the hippocampus
or the thalamus. This is consistent with the observation that differe
nt nAChRs modulate dopamine release as compared with norepinephrine re
lease. The effect of (+/-)-epibatidine on both [H-3]-dopamine and [H-3
]-norepinephrine release was tetrodotoxin-sensitive, suggesting the in
volvement of sodium channels. (+/-)-Epibalidine (1-3 mu g/kg s.c.) pro
duced ipsilateral turning in the unilaterally [6(OH)-DA]-lesioned rat.
This effect was mimicked by (-)-nicotine (0.35 mg/kg s.c.). Both (+/-
)-epibatidine- and (-)-nicotine-induced turning were significantly inh
ibited by mecamylamine (3 mg/kg s.c.), indicating that the turning res
ponse was mediated by nAChRs. (+/-)-Epibatidine also increased locomot
or activity in a dose-dependent manner, (+/-)-Epibatidine-induced hype
ractivity was blocked by D1 and D2 receptor antagonists, SCM 23390 and
eticlopride, respectively, suggesting that both dopamine receptor sub
types might be required for the locomotor effect of (+/-)-epibatidine.
These results demonstrate that (+/-)-epibatidine displays nAChR agoni
st activity in the rat CNS and that certain effects are mediated via n
AChR-stimulated catecholamine release and subsequent activation of cor
responding receptors.